Trend of HIV transmitted drug resistance before and after implementation of HAART regimen restriction in the treatment of HIV-1 infected patients in southern Taiwan-Reference-Cited by-同舟云学术

Trend of HIV transmitted drug resistance before and after implementation of HAART regimen restriction in the treatment of HIV-1 infected patients in southern Taiwan

Published:2019-08-23 Issue:1 Volume:19 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Weng Ya-Wei,Chen I-Tzu,Tsai Hung-Chin^ORCID,Wu Kuan-Sheng,Tseng Yu-Ting,Sy Cheng-Len,Chen Jui-Kuang,Lee Susan Shin-Jung,Chen Yao-Shen

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-019-4389-1.pdf

Reference36 articles.

1. Palella FJ Jr, Armon C, Buchacz K, Cole SR, Chmiel JS, Novak RM, et al. The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. Ann Intern Med. 2009;151:73–84.

2. Kuritzkes DR, Lalama CM, Ribaudo HJ, Marcial M, Meyer WA 3rd, Shikuma C, et al. Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts Virologic failure of an Efavirenz-based regimen in treatment-naive HIV-1–infected subjects. J Infect Dis. 2008;197:867–70. https://doi.org/10.1086/528802 .

3. Wittkop L, Gunthard HF, de Wolf F, Dunn D, Cozzi-Lepri A, de Luca A, et al. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis. 2011;11:363–71. https://doi.org/10.1016/S1473-3099(11)70032-9 .

4. Pham QD, Wilson DP, Law MG, Kelleher AD, et al. Global burden of transmitted HIV drug resistance and HIV-exposure categories: a systematic review and meta-analysis. AIDS. 2014;28(18):2751–62. https://doi.org/10.1097/QAD.0000000000000494 .

5. Stadeli KM, Richman DD. Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review. Antivir Ther. 2013;18(1):115–23. https://doi.org/10.3851/IMP2437 .

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of transmitted drug resistance and phylogenetic analysis of HIV-1 among antiretroviral therapy-naïve patients in Northern Vietnam from 2019 to 2022;Global Health & Medicine;2024-04-30

2. Retrospective Study on Genetic Diversity and Drug Resistance among People Living with HIV at an AIDS Clinic in Beijing;Pharmaceuticals;2024-01-16

3. Prevalence of HIV-1 drug resistance among patients with high viral loads while on second-line antiretroviral treatment in Butha-Buthe and Mokhotlong, Lesotho;The Journal of Medical Laboratory Science and Technology of South Africa;2023-12

4. A Phase IV Study on Safety, Tolerability and Efficacy of Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate in Treatment Naïve Adult Indian Patients Living with HIV-1;Pragmatic and Observational Research;2022-08

5. High prevalence of HIV-1 transmitted drug resistance and factors associated with time to virological failure and viral suppression in Taiwan;Journal of Antimicrobial Chemotherapy;2021-10-14